# Intratympanic Steroid Treatment For The Prevention Of Inner Ear Toxicity Associated With Systemic Treatment With Cisplatin.

> **NCT01285674** · NA · UNKNOWN · sponsor: **Ziv Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Cisplatin
- Ototoxicity
- Intratympanic Steroids

## Interventions

- **DRUG:** Intra-tympanic Cisplatinum

## Key facts

- **NCT ID:** NCT01285674
- **Lead sponsor:** Ziv Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01285674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01285674, "Intratympanic Steroid Treatment For The Prevention Of Inner Ear Toxicity Associated With Systemic Treatment With Cisplatin.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01285674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*